Abstract
OBJECTIVE
Subclinical hypothyroidism (SCH) is defined as high levels of TSH in the presence of normal levels of serum FT4. Since thyroid peroxidase (TPO) plays a key role in thyroid hormone synthesis, variations in the TPO gene can change the enzyme structure and result in the production of anti-TPO antibodies. The aim of this study was to examine the relationship between the Asn698Thr (A2095C) and Thr725Pro (A2173C) polymorphisms of the TPO gene and anti-TPO levels in patients with SCH.
DESIGN
In this study, 150 individuals (75 cases and 75 controls), aged 19–75 years, were selected randomly by a clinician. The thyroid function tests included were FT3, FT4, TSH and anti-TPO antibodies using ELISA. The TPO gene polymorphisms were examined by PCR-RFLP.
RESULTS
Anti-TPO levels in the experimental group was significantly increased (P=0.020). The A2095C genotype frequency in the experimental and control groups were 37.3% vs 34.7% for the AA healthy genotype, 20% vs 46.7% for AC and 42.7% vs 18.6% for CC, respectively (P=0.001). The A2173C genotype frequency in the experimental and control groups were 22.6% vs 68% for healthy AA, 40% vs 25.3% for AC and 37.4% vs 6.7% for CC, respectively (P <0.001). The increased anti-TPO antibodies were significantly associated with the A2173C polymorphism (P=0.035). The findings showed that the chance (odds ratio) of developing subclinical hypothyroidism in individuals who had C alleles was 1.5 and 5.6-fold higher than in individuals without these alleles in the A2095C and A2173C regions, respectively.
CONCLUSIONS
Determination of anti-TPO antibody levels and exon 12 TPO gene polymorphisms in patients with SCH can be helpful for prediction of overt hypothyroidism.
Article PDF
Similar content being viewed by others
References
Faam B, Daneshpour MS, Azizi F, Salehi M, Hedayati M, 2012 Association between TPO gene polymorphisms and Anti-TPO level in Tehranian population: TLGS. Gene 498: 116–119.
Brčić L, Barić A, Gračan S, et al, 2016 Association of established thyroid peroxidase autoantibody (TPOAb) genetic variants with Hashimoto’s thyroiditis. Autoimmunity 1–6.
Cooper DS, 2001 Subclinical hypothyroidism. New England Journal of Medicine 345: 260–265.
Hollowell JG, Staehling NW, Flanders WD, et al, 2002 Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87: 489–499.
Karmisholt J, Andersen S, Laurberg P, 2008 Variation in thyroid function tests in patients with stable untreated subclinical hypothyroidism. Thyroid 18: 303–3081
Fatourechi, V, 2009 Subclinical hypothyroidism: an update for primary care physicians. Mayo Clin Proc 84: 65–71.
Vanderpump MPJ, Tunbridge WMG, French J, et al, 1995 The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin endocrinol 43: 55–68.
Kimura S, Hong YS, Kotani T, Ohtaki S, Kikkawa F, 1989 Structure of the human thyroid peroxidase gene: comparison and relationship to the human myeloperoxidase gene. Biochemistry 28: 4481–4489.
Andersen S, Pedersen KM, Bruun NH, Laurberg P, 2002 Narrow individual variations in serum T4 and T3 in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab 87: 1068–1072.
Endo Y, Onogi S, Umeki K, et al, 1995 Regional localization of the gene for thyroid peroxidase to human chromosome 2p25 and mouse chromosome 12C. Genomics 25: 760–761.
Fugazzola L, Cerutti N, Mannavola D, et al, 2003 Monoallelic expression of mutant thyroid peroxidase allele causing total iodide organification defect. J Clin Endocrinol Metab 88: 3264–3271.
Fugazzola L, Mannavola D, Vigone MC, et al, 2005 Total iodide organification defect: clinical and molecular characterization of an Italian family. Thyroid 15: 1085–1088.
Czarnocka B, Ruf J, Ferrand M, Carayon P, Lissitzky S, 1985 Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases. FEBS letters 190: 147–152.
Portmann L, Hamda N, Heinrich G, Degroo LJ, 1985 Anti-thyroid peroxidase antibody in patients with autoimmune thyroid disease: possible identity with anti-microsomal antibody. J Clin Endocrinol Metab 61: 1001–1003.
Balmiki N, Bankura B, Guria S, et al, 2014 Genetic analysis of thyroid peroxidase (TPO) gene in patients whose hypothyroidism was found in adulthood in West Bengal, India. Endoc Jl 61: 289–296.
Hedayati M, Jahromi MS, Yeganeh MZ, et al, 2010 Association between serum level of anti-TPO titer and polymorphisms G1193/C Exon 8 and C2145/T Exon 12 of thyroid peroxidase gene in an Iranian population. Int J Endocrinol Metab 8: 64–67.
Schultheiss UT, Teumer A, Medici M, et al, 2015 A genetic risk score for thyroid peroxidase antibodies associates with clinical thyroid disease in community-based populations. J Clin Endocrinol Metab 100:E799–807.
Abramowicz MJ, Targovnik HM, Varela V, et al, 1992 Identification of a mutation in the coding sequence of the human thyroid peroxidase gene causing congenital goiter. J Clin Invest 90: 1200.
Kotani T, Umeki K, Kawano JI, et al, 2003 Partial iodide organification defect caused by a novel mutation of the thyroid peroxidase gene in three siblings. Clin Endocrinol 59: 198–206.
Ladenson PW, Singer PA, Ain KB, et al, 2000 American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Int Med 160: 1573–1575.
Bikker H, Baas F, de Vijlder JJ, 1997 Molecular Analysis of Mutated Thyroid Peroxidase Detected in Patients with Total Iodide Organification Defects 1. J Clin Endocrinol Metab 82: 649–653.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Khoshi, A., Sirghani, A., Ghazisaeedi, M. et al. Association between TPO Asn698Thr and Thr725Pro gene polymorphisms and serum anti-TPO levels in Iranian patients with subclinical hypothyroidism. Hormones 16, 75–83 (2017). https://doi.org/10.14310/horm.2002.1721
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.14310/horm.2002.1721